These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2464665)

  • 1. [Alpha-fetoprotein and trisomy 21].
    Guibaud S; Boisson C; Simplot A; Thoulon JM; Favier JP; Guibaud P; Robert JM
    J Genet Hum; 1988 Aug; 36(4):347-51. PubMed ID: 2464665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers of trisomy 21 in amniotic fluid.
    Spencer K; Muller F; Aitken DA
    Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AFP and age screening for Down syndrome.
    Wald N; Cuckle H
    Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
    Hsu JJ; Hseih TT; Liou JD; Soong YK
    J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
    Ashwood ER; Cheng E; Luthy DA
    Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
    Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
    Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
    Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
    Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
    Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
    Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum].
    Veress L; Szabó M; Polgár K; Takács L; Papp Z
    Orv Hetil; 1988 Jul; 129(31):1677. PubMed ID: 2476703
    [No Abstract]   [Full Text] [Related]  

  • 16. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
    Eloranta ML; Heinonen S; Kirkinen P
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
    Reynolds TM; Vranken G; Van Nueten J; Aldis J
    Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
    Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
    Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.